| 2D Structure | |
| CID | 5881 |
| Target | / |
| IUPAC Name | (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one |
| InChI | InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1 |
| InChI Key | FMGSKLZLMKYGDP-USOAJAOKSA-N |
| Canonical SMILES | CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C |
| Isomeric SMILES | C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C |
| Molecular Formula | C19H28O2 |
| Molecular Weight | 288.4 |
| synonyms | ['Dehydroepiandrosterone', 'DHEA', 'PRASTERONE', '53-43-0', 'Dehydroisoandrosterone', 'Androstenolone', 'trans-Dehydroandrosterone', 'Diandrone', 'Psicosterone', 'Diandron', '3beta-hydroxyandrost-5-en-17-one', 'Prestara', '17-Hormoforin', '17-Chetovis', 'Andrestenol', 'Intrarosa', 'Prasterona', 'Siscelar plus', '3-beta-Hydroxy-5-androsten-17-one', '5,6-Didehydroisoandrosterone', 'Prasteronum', 'Vaginorm', '5,6-Dehydroisoandrosterone', 'Caswell No. 051F', 'Epiandrosterone, 5-dehydro-', '5,6-Dehydroisoandrostorone', 'Biolaif', 'CCRIS 3277', '(3-beta)-3-Hydroxyandrost-5-en-17-one', 'EM-760', 'GL 701', 'EPA Pesticide Chemical Code 126510', 'Androst-5-en-17-one, 3-hydroxy-, (3beta)-', 'Prasteronum [INN-Latin]', 'Prasterona [INN-Spanish]', 'NSC 9896', 'NSC-9896', 'EINECS 200-175-5', 'UNII-459AG36T1B', 'BRN 2058110', 'Androst-5-en-17-one, 3-beta-hydroxy-', 'DTXSID4020379', 'CHEBI:28689', 'dehydroepiandrostenedione', 'NSC9896', '459AG36T1B', '3-beta-hydroxyandrost-5-en-17-one', 'Androst-5-en-17-one, 3beta-hydroxy-', 'DTXCID40379', 'EC 200-175-5', 'Androst-5-en-17-one, 3-hydroxy-, (3-beta)-', '4-08-00-00994 (Beilstein Handbook Reference)', 'Prasteronum (INN-Latin)', 'Prasterona (INN-Spanish)', 'PRASTERONE (MART.)', 'PRASTERONE [MART.]', 'Fidelin', 'GL701', '5 Androsten 3 beta hydroxy 17 one', '5-Androsten-3-beta-hydroxy-17-one', 'A14AA07', 'G03XX01', '200-175-5', '5-Dehydroepiandrosterone', 'Dehydro-epi-androsterone', '(+)-Dehydroisoandrosterone', 'dehydroepiandrosterone (dhea)', '3beta-hydroxy-5-androsten-17-one', 'Astenile', 'Deandros', '5-Androsten-3beta-ol-17-one', 'DEHYDROISOANDOSTERONE', 'dehydroepiandosterone', 'Androst-5-en-17-one, 3-hydroxy-, (3.beta.)-', '(3beta)-3-hydroxyandrost-5-en-17-one', 'CHEMBL90593', '(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one', 'D5-Androsten-3beta-ol-17-one', 'Androst-5-ene-3beta-ol-17-one', '3beta-Hydroxy-D5-androsten-17-one', 'Dehydro Epiandrosterone', '(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-3,4,7,8,9,10,11,12,13,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one', 'AND', 'Prasterone [INN]', 'CAS-53-43-0', 'SMR000059075', 'Androst-5-en-17-one, 3.beta.-hydroxy-', 'SR-01000075815', 'Prasterone [USAN:INN]', 'Dehydro Epiandrosterone (1.0 mg/mL in Acetonitrile)', '5-Androsten-3.beta.-ol-17-one', 'Anastar', 'Inflabloc', 'Aslera', 'Fidelin T', 'Androst-5-en-17-one, 3-hydroxy-, (3b)-', 'DHEA; Prasterone', 'NCGC00093802-04', 'NCGC00093802-06', 'Biolaif (TN)', 'MFCD00003613', '5-dehydro-Epiandrosterone', 'Prasterone (USAN/INN)', 'trans-de-hydroandrosterone', 'PRASTERONE [USAN]', 'bmse000665', 'Androsten-3beta-ol-17-one', 'PRASTERONE [WHO-DD]', 'BIDD:PXR0080', 'Lopac0_000368', 'SCHEMBL24156', 'MLS001066350', 'MLS001333231', 'MLS001333232', 'MLS001424274', '5-Androsten-3B-ol-17-one', 'D5-Androsten-3b-ol-17-one', 'GTPL2370', 'Androst-5-ene-3b-ol-17-one', 'PRASTERONE [ORANGE BOOK]', '3b-Hydroxyandrost-5-en-17-one', '5-Androsten-3-beta-ol-17-one', 'BCPE00002', '3b-Hydroxy-D5-androsten-17-one', '3beta-Hyroxyandrost-5-en-17-one', 'BCPP000260', 'DEHYDROEPIANDROSTERONE [MI]', 'EL-10', 'HMS2052P11', 'HMS2090C04', 'HMS2232K11', 'IM 28', 'trans-Dehydroandrosterone, >=99%', '3-beta-hydroxy-5-androsten-17-on', 'BCP02453', 'IPL-1001', '3beta-hydroxy-androst-5-en-17-one', '3beta-Hydroxyandrost-5-ene-17-one', 'Tox21_111222', 'Tox21_201996', 'Tox21_302761', 'BDBM50223368', 'CMC_13435', 'Delta5-androsten-3-beta-ol-17-one', 'DL-373', 'GL-701', 'LMST02020021', 'PB-007', 's2604', 'DEHYDROEPIANDROSTERONE [VANDF]', '3.beta.-Hydroxyandrost-5-en-17-one', '5-Androsten-3beta-ol-17-one; DHEA', 'AKOS007930299', 'AKOS015951378', 'Tox21_111222_1', 'BCP9000602', 'CCG-101190', 'CS-1667', 'DB01708', 'FD12003', 'GS-0906', 'IP-1001', 'NC00440', 'SH-K-04828', 'NCGC00093802-09', 'NCGC00256412-01', 'NCGC00259545-01', '(1S,5S,11S,15S,2R,10R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0<2,7>.0<11,15> ]heptadec-7-en-14-one', '(3beta)-3-Hydroxyandrost-5-ene-17-one', 'AC-28716', 'HY-14650', 'NCI60_042215', 'Prasterone (DHEA; Dehydroepiandrosterone)', '(3beta)-3-hydroxy-Androst-5-en-17-one', 'D0044', 'EU-0100368', 'NS00000508', 'Androst-5-en-17-one, 3beta-hydroxy- (8CI)', 'C01227', 'D 4000', 'D-0340', 'D08409', '(3alpha,8alpha)-3-hydroxyandrost-5-en-17-one', 'AB00375810-06', 'AB00375810_09', 'Dehydroepiandrosterone (DHEA), 1mg/ml in Methanol', 'Q408376', 'SR-01000075815-1', 'SR-01000075815-4', 'BRD-K41256143-001-12-7', '(3beta,16alpha)-3,16-dihydroxy-androst-5-en-17-one', 'Androst-5-en-17-one, 3-hydroxy-, (3beta)- (9CI)', '1A9D2040-240C-427D-ADE4-0CB700B785CB', 'Prasterone (DHEA; Dehydroepiandrosterone) 1.0 mg/ml in Acetonitrile', '(1S,2R,5S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-one', '(3S,8R,10R,13S)-3-Hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one', '105597-37-3', 'Dehydroepiandrosterone; trans-Dehydroandrosterone; Prasterone; 5-Androsten-3beta-ol-17-one; DHEA'] |
From Pubchem